Literature DB >> 27297212

Could stem cells be the future therapy for sepsis?

S Manoj Kumar Kingsley1, B Vishnu Bhat2.   

Abstract

The severity and threat of sepsis is well known, and despite several decades of research, the mortality continues to be high. Stem cells have great potential to be used in various clinical disorders. The innate ability of stem cells such as pluripotency, self-renewal makes them potential agents for therapeutic intervention. The pathophysiology of sepsis is a plethora of complex mechanisms which include the initial microbial infection, followed by "cytokine storm," endothelial dysfunction, coagulation cascade, and the late phase of apoptosis and immune paralysis which ultimately results in multiple organ dysfunction. Stem cells could potentially alter each step of this complex pathophysiology of sepsis. Multiple organ dysfunction associated with sepsis most often leads to death and stem cells have shown their ability to prevent the organ damage and improve the organ function. The possible mechanisms of therapeutic potential of stem cells in sepsis have been discussed in detail. The route of administration, dose level, and timing also play vital role in the overall effect of stem cells in sepsis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multiple organ dysfunction; Pathophysiology; Pluripotency; Sepsis; Stem cells; Therapeutic intervention

Mesh:

Substances:

Year:  2016        PMID: 27297212     DOI: 10.1016/j.blre.2016.05.004

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  3 in total

Review 1.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

2.  Human Adipose-Derived Mesenchymal Stem Cells Modify Lung Immunity and Improve Antibacterial Defense in Pneumosepsis Caused by Klebsiella pneumoniae.

Authors:  Desiree Perlee; Alex F de Vos; Brendon P Scicluna; Pablo Mancheño; Olga de la Rosa; Wilfried Dalemans; Peter Nürnberg; Eleuterio Lombardo; Tom van der Poll
Journal:  Stem Cells Transl Med       Date:  2019-04-29       Impact factor: 6.940

Review 3.  State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery.

Authors:  Hosanna Brave; Ronan MacLoughlin
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.